U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
Damlecovatein
INN  
Official Name English
319-537-Spike glycoprotein [537-glycine] (severe acute respiratory syndrome coronavirus 2 variant XBB.1.16 precursor) fusion protein with 319-537-spike glycoprotein (severe acute respiratory syndrome coronavirus 2 variant XBB.1.16 precursor)
Preferred Name English
damlecovatein [INN]
Common Name English
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), omicron lineage XBB.1.16 (Gisaid: EPI_ISL_17619088) spike (S) glycoprotein receptor binding domain (RBD) fragment (302-520, 1-219 in the current sequence), variant (K <sup>520</sup> >G <sup>21
Common Name English
Code System Code Type Description
FDA UNII
26JP6N8VU6
Created by admin on Wed Apr 02 20:42:06 GMT 2025 , Edited by admin on Wed Apr 02 20:42:06 GMT 2025
PRIMARY
CAS
3020658-23-2
Created by admin on Wed Apr 02 20:42:06 GMT 2025 , Edited by admin on Wed Apr 02 20:42:06 GMT 2025
PRIMARY
NCI_THESAURUS
C211718
Created by admin on Wed Apr 02 20:42:06 GMT 2025 , Edited by admin on Wed Apr 02 20:42:06 GMT 2025
PRIMARY
INN
13489
Created by admin on Wed Apr 02 20:42:06 GMT 2025 , Edited by admin on Wed Apr 02 20:42:06 GMT 2025
PRIMARY
ACTIVE MOIETY
Damlecovatein
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966